Description of Individual Course Units
|
Offered By |
Molecular Medicine |
Level of Course Unit |
Third Cycle Programmes (Doctorate Degree) |
Course Coordinator |
PROFESSOR DOCTOR MUKADDES GÜMÜŞTEKIN |
Offered to |
Doctorate Program Rare Diseases |
Course Objective |
The detailed course objectives are: to learn the general information and concepts about pharmacology and moleculer pharmacology, to have information about target molecules of drugs, like receptors, ion channels, enzymes, carrier molecules, to have information about moleculer models in drug-receptor interaction and radioligand binding methods, to have information about the mechanisms of action of drugs targeting intracellular molecules or cell components which is currently used or under development, to understand and interpret the drugs or treatment modalities which have roles in physiological and/or pathological processes and molecular structures. |
Learning Outcomes of the Course Unit |
||||||||||
|
Mode of Delivery |
Face -to- Face |
Prerequisites and Co-requisites |
None |
Recomended Optional Programme Components |
None |
Course Contents |
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Recomended or Required Reading |
Textbook(s): |
Planned Learning Activities and Teaching Methods |
Assessment Methods |
To be announced! |
Further Notes About Assessment Methods |
Students are expected to make power point presentation related a subject from molecular pharmacology. |
Assessment Criteria |
Students achievement will be measured by passing the final exam and making power point presentation related to a subject from course program. |
Language of Instruction |
Turkish |
Course Policies and Rules |
To be announced. |
Contact Details for the Lecturer(s) |
gumustek@deu.edu.tr, telephone number: 4123906 |
Office Hours |
To be announced. |
Work Placement(s) |
None |
Workload Calculation |
||||||||||||||||||||||||||||
|
Contribution of Learning Outcomes to Programme Outcomes |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|